Form D — Immunophotonics, Inc.
0001490953-26-000003 · filed Sep 4, 2026
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- —
- Total sold
- $10,147,612
- Minimum investment
- $100,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Immunophotonics, Inc.
- CIK
- 1490953
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 4340 Duncan Ave., Suite 212
ST. LOUIS, MO 63110 - Phone
- 314-501-1919
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Alexander Michael Hurst · Executive OfficerSt. Louis, MO Find on LinkedIn ↗
-
Robert H. Arch · Executive OfficerSt. Louis, MO Find on LinkedIn ↗
-
Miguel M. Zubizarreta · DirectorSt. Louis, MO Find on LinkedIn ↗
-
Luciano Alleruzzo · DirectorSt. Louis, MO Find on LinkedIn ↗
-
Jonathan Knowles · DirectorSt. Louis, MO, USA, MO Find on LinkedIn ↗
-
Wei Chen · DirectorSt. Louis, MO Find on LinkedIn ↗
-
Jacqueline Hess · DirectorSt. Louis, MO Find on LinkedIn ↗
-
Richard Levenson · DirectorSt. Louis, MO Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗